Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventionalPhase 3

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation

NCT ID: NCT04566328Sponsor: ECOG-ACRIN Cancer Research GroupLast updated: 2026-06-18

Summary

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Anti-inflammatory drugs, such as dexamethasone lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Adding bortezomib to daratumumab, lenalidomide, and dexamethasone may be more effective in shrinking the cancer or preventing it from returning, compared to continuing on daratumumab, lenalidomide, and dexamethasone.

Detailed description

PRIMARY OBJECTIVE: I. To determine if bortezomib, daratumumab and hyaluronidase-fihj (daratumumab), lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab and lenalidomide (DR) maintenance after standard induction therapy with daratumumab, lenalidomide and dexamethasone (DRd) results in superior overall survival compared to DRd consolidation followed by DR maintenance, in minimal residual disease (MRD) positive patients. SECONDARY OBJECTIVES: I. To determine if Btz-DRd consolidation followed by DR maintenance after standard induction therapy with DRd results in superior overall survival compared to DRd consolidation followed by DR maintenance in MRD negative patients. II. To determine if Btz-DRd consolidation followed by DR maintenance after standard induction therapy with DRd results in superior progression-free survival compared to DRd consolidation followed by DR maintenance in both MRD positive and MRD negative patients. III. To describe and compare the incidence of toxicities during consolidation between Btz-DRd and DRd arms. IV. To assess the improvement in MRD negative rate with consolidation among patients who are MRD positive after induction. V. To assess the sustained MRD negative rate among patients who are MRD negative after induction. PATIENT REPORTED OUTCOMES (PRO) OBJECTIVES: I. To quantify the extent to which the addition of bortezomib to DRd over consolidation treatment contributes to neuropathy and associated physical and functional impairments. (Primary PRO Objective) II. To evaluate the rate of resolution of neurotoxicity and associated physical and functional impairments following completion of consolidation therapy. (Secondary PRO Objective) III. To investigate the relationship between MRD status and patient reported health-related quality of life outcomes. (Exploratory PRO Objective) IV. To evaluate attributes of select patient reported treatment-emergent symptomatic adverse events (PRO- Common Terminology Criteria for Adverse Events \[CTCAE\]) longitudinally and compare responses with provider-reported adverse events. (Exploratory PRO Objective) V. To tabulate PRO compliance and completion rates. (Exploratory PRO Objective) IMAGING OBJECTIVES: I. To evaluate the association between post-induction fludeoxyglucose F-18 (18F-FDG) positron emission tomography (PET)/computed tomography (CT) and patient outcomes (overall survival \[OS\] and progression-free survival \[PFS\]). (Primary Imaging Objective) II. To evaluate the association between baseline 18F-FDG PET/CT and patient outcomes (PFS and OS). (Secondary Imaging Objective) III. To compare overall survival with the addition of Bortezomib to consolidation DRd therapy among 18F-FDG PET/CT-positive and 18F-FDG PET/CT-negative subgroups. (Secondary Imaging Objective) IV. To evaluate the ability of baseline 18F-FDG PET/CT to predict post-induction depth of response as measured by MRD assessment. (Secondary Imaging Objective) V. To evaluate the ability of post-induction 18F-FDG PET/CT to predict MRD conversion post-consolidation. (Secondary Imaging Objective) VI. To utilize 18F-FDG PET/CT, standard risk factors and clinical data to identify distinct subgroups with differing patient outcomes (PFS and OS). (Exploratory Imaging Objective) VII. To compare the various qualitative 18F-FDG PET/CT criteria to determine which criteria yields superior risk stratification. (Exploratory Imaging Objective) OUTLINE: ARM A (INDUCTION): All patients receive standard induction therapy comprising the following: daratumumab subcutaneously (SC) on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide orally (PO) daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity. After completion of standard induction therapy, patients are randomized to 1 of 2 arms. ARM B: CONSOLIDATION: Patients receive bortezomib SC on days 1, 8, and 15, daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21 and daratumumab SC on day 1. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. ARM C: CONSOLIDATION: Patients receive daratumumab SC on day 1, lenalidomide PO daily on days 1-21, and dexamethasone PO on days 1, 8, 15, and 22. Treatment repeats every 28 days for 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE: Patients receive lenalidomide PO daily on days 1-21, and daratumumab SC on day 1. Cycles repeats every 28 days in the absence of disease progression or unacceptable toxicity. After completion of study treatment, patients are followed up every 3 months if less than 2 years from study entry, every 6 months if 2-5 years from study entry, then annually for up to 15 years from study entry.

Arms & interventions

  • DrugBortezomib

    Given SC

  • BiologicalDaratumumab and Hyaluronidase-fihj

    Given SC

  • DrugDexamethasone

    Given PO

  • DrugLenalidomide

    Given PO

  • OtherQuality-of-Life Assessment

    Ancillary studies

Outcome measures

Primary

  • Consolidation overall survival

    Will be estimated using the Kaplan-Meier (KM) method and compared using a stratified log-rank test. Stratified cox proportional hazards regression will produce treatment hazard ratio (bortezomib, daratumumab and hyaluronidase-fihj (daratumumab), lenalidomide and dexamethasone \[Btz-DRd\] then daratumumab, lenalidomide and dexamethasone \[DRd\] then daratumumab and lenalidomide \[DR\]).

    Time frame: Time from Step 2 randomization at the start of consolidation to death or to the date last known alive, assessed up to 15 years

Secondary

  • Consolidation progression-free survival

    Time frame: Time from Step 2 randomization at the start of consolidation until the earlier of progression or death due to any cause, assessed up to 15 years

  • Incidence of adverse events

    Time frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance).

  • Incidence of grade 3 or higher non-hematologic adverse events

    Time frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance).

  • Incidence of grade 3 or higher adverse events

    Time frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance).

  • Best response

    Time frame: During induction, consolidation, and maintenance; a period of up to 42 months (9 months of induction, 9 months of consolidation, and up to 2 years of maintenance).

  • FACT-Ntx TOI recovery rate (Patient reported outcome [PRO])

    Time frame: From end of induction through consolidation up to 1 year of maintenance, up to 21 weeks

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * STEP 0 - Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0-2 (PS 3 allowed if secondary to pain) * STEP 0 - Patient must have newly diagnosed multiple myeloma (MM) by International Myeloma Working Group (IMWG) criteria * STEP 0 - Patient must agree to register to the mandatory REVLIMID Risk Evaluation and Mitigation Strategy (RevREMS) program and be willing and able to comply with the requirements of RevREMS * STEP 0 - Patient must be able to undergo diagnostic bone marrow aspirate following preregistration. * NOTE: Bone marrow aspirate specimen must be submitted to Adaptive Biotechnologies for clonoSEQ Assay * NOTE: Adaptive Biotechnologies will release results to the diagnostic Portal from the Clonality (ID) test within fourteen (14) days of receipt and reconciliation of fresh bone marrow specimen to the submitting institution * STEP 1 - Patient must meet all eligibility criteria in STEP 0 with exception of allergy requirement * STEP 1 - Institution must have received the Clonality (ID) test results from Adaptive Biotechnologies and dominant sequences were identified * STEP 1 - Patient must have standard risk MM as defined by the Revised International Staging System (RISS) stage I or II * NOTE: R-ISS stage is based on serum beta2 microglobulin, albumin and lactate dehydrogenase (LDH) levels along with presence of chromosomal abnormalities (CA) detected by interphase fluorescent in situ hybridization (iFISH). Presence of del(17p), t(4;14), and/or t(14;16) is considered high risk and absence of these, including any other findings, are standard risk * R-ISS stage * Stage I: ISS stage I \[beta2 macroglobulin \< 3.5 mg/L, albumin \> 3.5 g/dL\] AND standard-risk CA AND normal LDH * Stage II: Not R-ISS stage I or III * Stage III: ISS stage III \[beta2 macroglobulin \> 5.5 mg/L\] AND high-risk CA OR high LDH (\> upper limit of normal) \[patients with stage III are ineligible\] * STEP 1 - Patient must have measurable or evaluable disease as defined by having one or more of the following, obtained within 28 days prior to registration: * \>= 1 g/dL monoclonal protein (M-protein) on serum protein electrophoresis * \>= 200 mg/24 hours of monoclonal protein on a 24-hour urine protein electrophoresis * Involved free light chain \>= 10 mg/dL or \>= 100 mg/L AND abnormal serum immunoglobulin kappa to lambda free light chain ratio (\< 0.26 or \> 1.65) * Monoclonal bone marrow plasmacytosis \>= 30% (evaluable disease) * STEP 1 - Patients must have a serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), and serum free light chain (FLC) assay performed within 28 days prior to registration. In addition, a bone marrow biopsy and/or aspirate is required within 28 days if bone marrow is being followed for response * NOTE: UPEP (on a 24-hour collection) is required, no substitute method is acceptable. Urine must be followed monthly if the baseline urine M-spike is \>= 200 mg/24 hr. Please note that if both serum and urine M-components are present, both must be followed in order to evaluate response * NOTE: The serum free light chain test is required to be done if the patient does not have measurable disease in the serum or urine. Measurable disease in the serum is defined as having a serum M-spike \>= 1 g/dL. Measurable disease in the urine is defined as having a urine M-spike \>= 200 mg/24 hr * STEP 1 - Calculated creatinine clearance \> 30 mL/min (obtained =\< 14 days prior to Step 1 registration) * STEP 1 - Absolute neutrophil count (ANC) \>= 1000/mm\^3 (obtained =\< 14 days prior to Step 1 registration) * STEP 1 - Untransfused platelet count \>= 75,000/mm\^3 (obtained =\< 14 days prior to Step 1 registration) * STEP 1 - Hemoglobin \>= 8.0 g/dL (obtained =\< 14 days prior to Step 1 registration) * STEP 1 - Total bilirubin =\< 1.5 x ULN (institutional upper limit of normal) (obtained =\< 14 days prior to Step 1 registration) * STEP 1 - Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =\< 3 x ULN (obtained =\< 14 days prior to Step 1 registration) * STEP 1 - Patient must have received no more than one cycle (28 days or less) of prior chemotherapy and no more than 160 mg of prior dexamethasone (or equivalent dose of prednisone) for treatment of symptomatic myeloma. Patient must not have been exposed to daratumumab for treatment of symptomatic myeloma. Prior radiation therapy to symptomatic lesions is allowed provided there are no residual toxicity related to radiation and blood counts meet the study requirements. Radiation treatment must be completed at least 14 days prior to Step 1 registration * STEP 1 - Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of randomization are eligible for this trial * STEP 1 - For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated * STEP 1 - Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load * STEP 1 - Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * STEP 1 - Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better. Patients must not have evidence of current uncontrolled cardiovascular conditions, including hypertension, cardiac arrhythmias, congestive heart failure, unstable angina, or myocardial infarction within 6 months prior to Step 1 registration * STEP 1 - Patient may have a history of current or previous deep vein thrombosis (DVT) or pulmonary embolism (PE) but must be willing to take some form of anti-coagulation as prophylaxis if they are not currently on full-dose anticoagulation * STEP 1 - Patients with a history of chronic obstructive pulmonary disease (COPD) must have FEV1 testing done within 28 days prior to Step 1 registration and the forced expiratory volume in 1 second (FEV1) must be \> 50% of predicted normal * STEP 2 - Institution must have received Tracking (MRD) test results from Adaptive Biotechnologies * STEP 2 - Patient must have completed the Step 1 Induction phase of this protocol without experiencing progression * STEP 2 - Patient must be registered to Step 2 within 8 weeks of completing Step 1 Induction Treatment, counting from last day of completion of last cycle * STEP 2 - Patient must have an ECOG performance status (PS) of 0-2 (PS 3 allowed if secondary to pain) * STEP 2 - Any adverse event(s) related to Step 1 Induction Treatment must have resolved to grade 2 or less * STEP 2 - Hemoglobin \>= 8 g/dL (obtained within 14 days prior to Step 2 randomization) * STEP 2 - Platelet count \>= 50,000/mm\^3 (obtained within 14 days prior to Step 2 randomization) * STEP 2 - Absolute neutrophil count (ANC) \>= 1000/mm\^3 (obtained within 14 days prior to Step 2 randomization) * STEP 2 - Calculated creatinine clearance \>= 30 mL/min (obtained within 14 days prior to Step 2 randomization) * STEP 2 - Total bilirubin =\< 1.5 x ULN (Institutional upper limit of normal) (obtained within 14 days prior to Step 2 randomization) * STEP 2 - ALT and AST \< 3 x ULN (obtained within 14 days prior to Step 2 randomization) Exclusion Criteria: * STEP 0 - Patient must not have any known allergies, hypersensitivity, or intolerance to corticosteroids, monoclonal antibodies or human proteins, or their excipients (refer to respective package inserts or Investigator's Brochure), or known sensitivity to mammalian-derived products * STEP 1 - Women must not be pregnant or breast-feeding due to the potential harm and teratogenic effects to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All females of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to Step 1 registration to rule out pregnancy and again within 24 hours prior to the first dose of lenalidomide. Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: * Has achieved menarche at some point, * Has not undergone a hysterectomy or bilateral oophorectomy; or * Has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months) * STEP 1 - Women of childbearing potential must not expect to conceive children by using accepted and effective method(s) of contraception (for this protocol defined as the use of TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting protocol treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 3 months days after the last dose of protocol treatment) OR by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence \[e.g., calendar, ovulation, symptothermal, post-ovulation methods\] and withdrawal are not acceptable methods of contraception). Men must not expect to father children by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence \[e.g., calendar, ovulation, symptothermal, post-ovulation methods\] and withdrawal are not acceptable methods of contraception) OR use a latex condom during sexual contact with a female of child bearing potential while participating in the study and for at least 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment * STEP 1 - Patient must not have peripheral neuropathy \>= grade 2 on clinical examination or grade 1 with pain at time of Step 1 registration * STEP 1 - Patient must not have any serious medical or psychiatric illness that could, in the investigator's opinion, potentially interfere with the completion of treatment according to this protocol * STEP 1 - Patient must not have moderate or severe persistent asthma within the past 2 years, or uncontrolled asthma of any classification * NOTE: Patients who currently have controlled intermittent asthma or controlled mild persistent asthma are allowed to register * STEP 1 - Patient must not receive any other concurrent chemotherapy, or any ancillary therapy considered investigational while on this protocol * NOTE: Bisphosphonates are considered to be supportive care rather than therapy, and are thus allowed while on protocol treatment * STEP 2 - Patient must not have received any non-protocol therapy outside of the assigned Step 1 Induction treatment including stem cell transplant * STEP 2 - Women must not be pregnant or breast-feeding due to the potential harm and teratogenic effects to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All females of childbearing potential must have a blood test or urine study with a sensitivity of at least 25 mIU/mL within 10-14 days prior to Step 2 randomization to rule out pregnancy and again within 24 hours prior to the first dose of lenalidomide. Females of childbearing potential must also agree to ongoing pregnancy testing while on protocol treatment. A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: * Has achieved menarche at some point, * Has not undergone a hysterectomy or bilateral oophorectomy; or * Has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months). * STEP 2 - Women of childbearing potential must not expect to conceive children by using accepted and effective method(s) of contraception (for this protocol defined as the use of TWO acceptable methods of birth control, one highly effective method and one additional effective method AT THE SAME TIME for 1) at least 28 days before starting protocol treatment; 2) while participating in the study; 3) during dose interruptions; and 4) for at least 3 months days after the last dose of protocol treatment) OR by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence \[e.g., calendar, ovulation, symptothermal, post-ovulation methods\] and withdrawal are not acceptable methods of contraception). Men must not expect to father children by practicing true abstinence from sexual intercourse for the duration of their participation in the study (periodic abstinence \[e.g., calendar, ovulation, symptothermal, post-ovulation methods\] and withdrawal are not acceptable methods of contraception) OR use a latex condom during sexual contact with a female of child bearing potential while participating in the study and for at least 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Men must also agree to abstain from donating sperm while on study treatment and for 3 months after the last dose of protocol treatment even if they have had a successful vasectomy. Both women and men must both agree to abstain from donating blood during study participation and for at least 28 days after the last dose of protocol treatment

Study locations (642)

Anchorage Associates in Radiation Medicine

Anchorage, Alaska, 98508

Suspended

Anchorage Radiation Therapy Center

Anchorage, Alaska, 99504

Suspended

Alaska Breast Care and Surgery LLC

Anchorage, Alaska, 99508

Suspended

Alaska Oncology and Hematology LLC

Anchorage, Alaska, 99508

Suspended

Alaska Women's Cancer Care

Anchorage, Alaska, 99508

Suspended

Anchorage Oncology Centre

Anchorage, Alaska, 99508

Suspended

Katmai Oncology Group

Anchorage, Alaska, 99508

Suspended

Providence Alaska Medical Center

Anchorage, Alaska, 99508

Suspended

Cancer Center at Saint Joseph's

Phoenix, Arizona, 85004

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

University of Arizona Cancer Center-Orange Grove Campus

Tucson, Arizona, 85704

Suspended

Banner University Medical Center - Tucson

Tucson, Arizona, 85719

Suspended

University of Arizona Cancer Center-North Campus

Tucson, Arizona, 85719

Suspended

Mercy Hospital Fort Smith

Fort Smith, Arkansas, 72903

Recruiting
Site Public Contact · Contact
800-378-9373
Jay W. Carlson · Principal Investigator

CHI Saint Vincent Cancer Center Hot Springs

Hot Springs, Arkansas, 71913

Suspended

CARTI Cancer Center

Little Rock, Arkansas, 72205

Recruiting
Site Public Contact · Contact
501-906-4199Research@CARTI.com
Jay W. Carlson · Principal Investigator

John L McClellan Memorial Veterans Hospital

Little Rock, Arkansas, 72205

Suspended

Mission Hope Medical Oncology - Arroyo Grande

Arroyo Grande, California, 93420

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Sutter Auburn Faith Hospital

Auburn, California, 95602

Suspended

Sutter Cancer Centers Radiation Oncology Services-Auburn

Auburn, California, 95603

Suspended

Alta Bates Summit Medical Center-Herrick Campus

Berkeley, California, 94704

Suspended

Providence Saint Joseph Medical Center/Disney Family Cancer Center

Burbank, California, 91505

Suspended

Mills-Peninsula Medical Center

Burlingame, California, 94010

Suspended

Sutter Cancer Centers Radiation Oncology Services-Cameron Park

Cameron Park, California, 95682

Suspended

Mercy Cancer Center - Carmichael

Carmichael, California, 95608

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Mercy San Juan Medical Center

Carmichael, California, 95608

Recruiting
Site Public Contact · Contact
916-556-3301OncologyResearch@DignityHealth.org
Shahzad Siddique · Principal Investigator

Eden Hospital Medical Center

Castro Valley, California, 94546

Suspended

Sutter Davis Hospital

Davis, California, 95616

Suspended

Mercy Cancer Center - Elk Grove

Elk Grove, California, 95758

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Palo Alto Medical Foundation-Fremont

Fremont, California, 94538

Suspended

Washington Hospital

Fremont, California, 94538

Suspended

Mercy Cancer Center

Merced, California, 95340

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Memorial Medical Center

Modesto, California, 95355

Suspended

Palo Alto Medical Foundation-Camino Division

Mountain View, California, 94040

Suspended

Palo Alto Medical Foundation-Gynecologic Oncology

Mountain View, California, 94040

Suspended

Sutter Cancer Research Consortium

Novato, California, 94945

Suspended

Palo Alto Medical Foundation Health Care

Palo Alto, California, 94301

Suspended

Mercy Cancer Center - Rocklin

Rocklin, California, 95765

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Sutter Cancer Centers Radiation Oncology Services-Roseville

Roseville, California, 95661

Suspended

Sutter Roseville Medical Center

Roseville, California, 95661

Suspended

Mercy Cancer Center - Sacramento

Sacramento, California, 95816

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Sutter Medical Center Sacramento

Sacramento, California, 95816

Suspended

California Pacific Medical Center-Pacific Campus

San Francisco, California, 94115

Suspended

Pacific Central Coast Health Center-San Luis Obispo

San Luis Obispo, California, 93401

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Mills Health Center

San Mateo, California, 94401

Suspended

Ridley-Tree Cancer Center

Santa Barbara, California, 93105

Suspended

Palo Alto Medical Foundation-Santa Cruz

Santa Cruz, California, 95065

Suspended

Santa Cruz Radiation Oncology Medical Group

Santa Cruz, California, 95065

Suspended

Mission Hope Medical Oncology - Santa Maria

Santa Maria, California, 93444

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Sutter Pacific Medical Foundation

Santa Rosa, California, 95403

Suspended

Saint Joseph's Medical Center

Stockton, California, 95204

Recruiting
Site Public Contact · Contact
209-461-5257
Shahzad Siddique · Principal Investigator

Palo Alto Medical Foundation-Sunnyvale

Sunnyvale, California, 94086

Suspended

Sutter Solano Medical Center/Cancer Center

Vallejo, California, 94589

Suspended

Woodland Memorial Hospital

Woodland, California, 95695

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Penrose-Saint Francis Healthcare

Colorado Springs, Colorado, 80907

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Colorado Springs, Colorado, 80907

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Saint Francis Cancer Center

Colorado Springs, Colorado, 80923

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

AdventHealth Porter

Denver, Colorado, 80210

Suspended

CommonSpirit Cancer Center Mercy

Durango, Colorado, 81301

Suspended

Mercy Medical Center

Durango, Colorado, 81301

Suspended

Saint Anthony Hospital

Lakewood, Colorado, 80228

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

AdventHealth Littleton

Littleton, Colorado, 80122

Suspended

Longmont United Hospital

Longmont, Colorado, 80501

Suspended

Rocky Mountain Cancer Centers-Longmont

Longmont, Colorado, 80501

Suspended

AdventHealth Parker

Parker, Colorado, 80138

Suspended

Saint Mary Corwin Medical Center

Pueblo, Colorado, 81004

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Saint Anthony North Hospital

Westminster, Colorado, 80023

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Smilow Cancer Hospital-Derby Care Center

Derby, Connecticut, 06418

Suspended

Smilow Cancer Hospital Care Center-Fairfield

Fairfield, Connecticut, 06824

Suspended

Smilow Cancer Hospital Care Center at Glastonbury

Glastonbury, Connecticut, 06033

Suspended

Smilow Cancer Hospital Care Center at Greenwich

Greenwich, Connecticut, 06830

Suspended

Smilow Cancer Hospital Care Center - Guilford

Guilford, Connecticut, 06437

Suspended

Hartford Hospital

Hartford, Connecticut, 06102

Suspended

Smilow Cancer Hospital Care Center at Saint Francis

Hartford, Connecticut, 06105

Suspended

Midstate Medical Center

Meriden, Connecticut, 06451

Suspended

The Hospital of Central Connecticut

New Britain, Connecticut, 06050

Suspended

Smilow Cancer Center/Yale-New Haven Hospital

New Haven, Connecticut, 06510

Suspended

Yale University

New Haven, Connecticut, 06520

Suspended

Yale-New Haven Hospital North Haven Medical Center

North Haven, Connecticut, 06473

Suspended

Smilow Cancer Hospital-Orange Care Center

Orange, Connecticut, 06477

Suspended

Smilow Cancer Hospital-Torrington Care Center

Torrington, Connecticut, 06790

Suspended

Smilow Cancer Hospital Care Center-Trumbull

Trumbull, Connecticut, 06611

Suspended

Smilow Cancer Hospital-Waterbury Care Center

Waterbury, Connecticut, 06708

Suspended

Smilow Cancer Hospital Care Center - Waterford

Waterford, Connecticut, 06385

Suspended

Beebe Medical Center

Lewes, Delaware, 19958

Active Not Recruiting

Beebe South Coastal Health Campus

Millville, Delaware, 19967

Active Not Recruiting

Delaware Clinical and Laboratory Physicians PA

Newark, Delaware, 19713

Active Not Recruiting

Helen F Graham Cancer Center

Newark, Delaware, 19713

Active Not Recruiting

Medical Oncology Hematology Consultants PA

Newark, Delaware, 19713

Active Not Recruiting

Christiana Care Health System-Christiana Hospital

Newark, Delaware, 19718

Active Not Recruiting

Beebe Health Campus

Rehoboth Beach, Delaware, 19971

Active Not Recruiting

TidalHealth Nanticoke / Allen Cancer Center

Seaford, Delaware, 19973

Suspended

Christiana Care Health System-Wilmington Hospital

Wilmington, Delaware, 19801

Active Not Recruiting

Sibley Memorial Hospital

Washington D.C., District of Columbia, 20016

Suspended

Holy Cross Hospital

Fort Lauderdale, Florida, 33308

Recruiting
Site Public Contact · Contact
eileen.georgi@holy-cross.com
Elie G. Dib · Principal Investigator

University of Florida Health Science Center - Jacksonville

Jacksonville, Florida, 32209

Suspended

Sacred Heart Hospital

Pensacola, Florida, 32504

Suspended

Saint Alphonsus Cancer Care Center-Boise

Boise, Idaho, 83706

Recruiting
Site Public Contact · Contact
734-712-3671stephanie.couch@stjoeshealth.org
Elie G. Dib · Principal Investigator

Saint Luke's Cancer Institute - Boise

Boise, Idaho, 83712

Suspended

Saint Alphonsus Cancer Care Center-Caldwell

Caldwell, Idaho, 83605

Recruiting
Site Public Contact · Contact
734-712-3671stephanie.couch@stjoeshealth.org
Elie G. Dib · Principal Investigator

Kootenai Health - Coeur d'Alene

Coeur d'Alene, Idaho, 83814

Suspended

Walter Knox Memorial Hospital

Emmett, Idaho, 83617

Suspended

Saint Luke's Cancer Institute - Fruitland

Fruitland, Idaho, 83619

Suspended

Idaho Urologic Institute-Meridian

Meridian, Idaho, 83642

Suspended

Saint Luke's Cancer Institute - Meridian

Meridian, Idaho, 83642

Suspended

Saint Alphonsus Cancer Care Center-Nampa

Nampa, Idaho, 83687

Recruiting
Site Public Contact · Contact
406-969-6060mccinfo@mtcancer.org
Elie G. Dib · Principal Investigator

Saint Luke's Cancer Institute - Nampa

Nampa, Idaho, 83687

Suspended

Kootenai Clinic Cancer Services - Post Falls

Post Falls, Idaho, 83854

Suspended

Kootenai Clinic Cancer Services - Sandpoint

Sandpoint, Idaho, 83864

Suspended

Saint Luke's Cancer Institute - Twin Falls

Twin Falls, Idaho, 83301

Suspended

OSF Saint Anthony's Health Center

Alton, Illinois, 62002

Recruiting
Site Public Contact · Contact
618-463-5623
Jay W. Carlson · Principal Investigator

Rush-Copley Medical Center

Aurora, Illinois, 60504

Suspended

Advocate Outpatient Center - Aurora

Aurora, Illinois, 60506

Suspended

Advocate Good Shepherd Hospital

Barrington, Illinois, 60010

Suspended

Illinois CancerCare-Bloomington

Bloomington, Illinois, 61704

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Loyola Center for Health at Burr Ridge

Burr Ridge, Illinois, 60527

Suspended

Illinois CancerCare-Canton

Canton, Illinois, 61520

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Memorial Hospital of Carbondale

Carbondale, Illinois, 62902

Recruiting
Site Public Contact · Contact
618-457-5200clinical.research@sih.net
Bryan A. Faller · Principal Investigator

SIH Cancer Institute

Carterville, Illinois, 62918

Recruiting
Site Public Contact · Contact
618-985-3333clinical.research@sih.net
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Carthage

Carthage, Illinois, 62321

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Centralia Oncology Clinic

Centralia, Illinois, 62801

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Saint Mary's Hospital

Centralia, Illinois, 62801

Suspended

Mount Sinai Hospital Medical Center

Chicago, Illinois, 60608

Suspended

John H Stroger Jr Hospital of Cook County

Chicago, Illinois, 60612

Suspended

University of Illinois

Chicago, Illinois, 60612

Active Not Recruiting

Advocate Illinois Masonic Medical Center

Chicago, Illinois, 60657

Suspended

AMG Crystal Lake - Oncology

Crystal Lake, Illinois, 60014

Suspended

Carle at The Riverfront

Danville, Illinois, 61832

Suspended

Cancer Care Specialists of Illinois - Decatur

Decatur, Illinois, 62526

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Decatur Memorial Hospital

Decatur, Illinois, 62526

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Northwestern Medicine Cancer Center Kishwaukee

DeKalb, Illinois, 60115

Recruiting
Site Public Contact · Contact
630-352-5360Donald.Smith3@nm.org
Renee Cheng · Principal Investigator

Illinois CancerCare-Dixon

Dixon, Illinois, 61021

Recruiting
Site Public Contact · Contact
815-285-7800
Bryan A. Faller · Principal Investigator

Advocate Good Samaritan Hospital

Downers Grove, Illinois, 60515

Suspended

Carle Physician Group-Effingham

Effingham, Illinois, 62401

Suspended

Crossroads Cancer Center

Effingham, Illinois, 62401

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Advocate Sherman Hospital

Elgin, Illinois, 60123

Suspended

Illinois CancerCare-Eureka

Eureka, Illinois, 61530

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Galesburg

Galesburg, Illinois, 61401

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Western Illinois Cancer Treatment Center

Galesburg, Illinois, 61401

Suspended

Northwestern Medicine Cancer Center Delnor

Geneva, Illinois, 60134

Recruiting
Site Public Contact · Contact
630-352-5360Donald.Smith3@nm.org
Renee Cheng · Principal Investigator

Advocate South Suburban Hospital

Hazel Crest, Illinois, 60429

Suspended

Loyola Medicine Homer Glen

Homer Glen, Illinois, 60491

Suspended

Illinois CancerCare-Kewanee Clinic

Kewanee, Illinois, 61443

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

AMG Libertyville - Oncology

Libertyville, Illinois, 60048

Suspended

Condell Memorial Hospital

Libertyville, Illinois, 60048

Suspended

Illinois CancerCare-Macomb

Macomb, Illinois, 61455

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois, 61938

Suspended

Loyola University Medical Center

Maywood, Illinois, 60153

Suspended

Marjorie Weinberg Cancer Center at Loyola-Gottlieb

Melrose Park, Illinois, 60160

Suspended

SSM Health Good Samaritan

Mount Vernon, Illinois, 62864

Recruiting
Site Public Contact · Contact
618-899-1894gayla.hall@ssmhealth.com
Jay W. Carlson · Principal Investigator

Carle BroMenn Medical Center

Normal, Illinois, 61761

Suspended

Carle Cancer Institute Normal

Normal, Illinois, 61761

Suspended

Cancer Care Center of O'Fallon

O'Fallon, Illinois, 62269

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

HSHS Saint Elizabeth's Hospital

O'Fallon, Illinois, 62269

Recruiting
Site Public Contact · Contact
217-876-4762morganthaler.jodi@mhsil.com
Bryan A. Faller · Principal Investigator

Advocate Christ Medical Center

Oak Lawn, Illinois, 60453-2699

Suspended

Illinois CancerCare-Ottawa Clinic

Ottawa, Illinois, 61350

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Advocate Lutheran General Hospital

Park Ridge, Illinois, 60068

Suspended

Illinois CancerCare-Pekin

Pekin, Illinois, 61554

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Peoria

Peoria, Illinois, 61615

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Methodist Medical Center of Illinois

Peoria, Illinois, 61636

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Peru

Peru, Illinois, 61354

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Valley Radiation Oncology

Peru, Illinois, 61354

Recruiting
Site Public Contact · Contact
815-664-4141
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Princeton

Princeton, Illinois, 61356

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

UW Health Carbone Cancer Center Rockford

Rockford, Illinois, 61114

Suspended

Southern Illinois University School of Medicine

Springfield, Illinois, 62702

Recruiting
Site Public Contact · Contact
217-545-7929
Bryan A. Faller · Principal Investigator

Springfield Clinic

Springfield, Illinois, 62702

Recruiting
Site Public Contact · Contact
800-444-7541
Bryan A. Faller · Principal Investigator

Springfield Memorial Hospital

Springfield, Illinois, 62781

Recruiting
Site Public Contact · Contact
217-528-7541pallante.beth@mhsil.com
Bryan A. Faller · Principal Investigator

Carle Cancer Center

Urbana, Illinois, 61801

Suspended

The Carle Foundation Hospital

Urbana, Illinois, 61801

Suspended

Northwestern Medicine Cancer Center Warrenville

Warrenville, Illinois, 60555

Recruiting
Site Public Contact · Contact
630-352-5360Donald.Smith3@nm.org
Renee Cheng · Principal Investigator

Illinois CancerCare - Washington

Washington, Illinois, 61571

Recruiting
Site Public Contact · Contact
309-243-3605andersonj@illinoiscancercare.com
Bryan A. Faller · Principal Investigator

Rush-Copley Healthcare Center

Yorkville, Illinois, 60560

Suspended

IU Health North Hospital

Carmel, Indiana, 46032

Not Yet Recruiting
Chelsea Young · Contact
317-278-5621youngchs@iu.edu
Rafat Abonour · Principal Investigator

Indiana University/Melvin and Bren Simon Cancer Center

Indianapolis, Indiana, 46202

Recruiting
Chelsea Young · Contact
317-278-5621youngchs@iu.edu
Rafat Abonour · Principal Investigator

IU Health Methodist Hospital

Indianapolis, Indiana, 46202

Not Yet Recruiting
Chelsea Young · Contact
317-278-5621youngchs@iu.edu
Rafat Abonour · Principal Investigator

Reid Health

Richmond, Indiana, 47374

Suspended

Mary Greeley Medical Center

Ames, Iowa, 50010

Recruiting
Site Public Contact · Contact
515-956-4132
Joseph J. Merchant · Principal Investigator

McFarland Clinic - Ames

Ames, Iowa, 50010

Recruiting
Site Public Contact · Contact
515-239-4734ksoder@mcfarlandclinic.com
Joseph J. Merchant · Principal Investigator

UI Health Care Mission Cancer and Blood - Ankeny Clinic

Ankeny, Iowa, 50023

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

McFarland Clinic - Boone

Boone, Iowa, 50036

Suspended

Saint Anthony Regional Hospital

Carroll, Iowa, 51401

Recruiting
Site Public Contact · Contact
515-689-7658sbenson@iora.org
Seema Harichand-Herdt · Principal Investigator

Mercy Hospital

Cedar Rapids, Iowa, 52403

Recruiting
Site Public Contact · Contact
319-365-4673
Deborah W. Wilbur · Principal Investigator

Oncology Associates at Mercy Medical Center

Cedar Rapids, Iowa, 52403

Recruiting
Site Public Contact · Contact
319-363-2690
Deborah W. Wilbur · Principal Investigator

Mercy Cancer Center-West Lakes

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
515-241-3305
Richard L. Deming · Principal Investigator

UI Health Care Mission Cancer and Blood - West Des Moines Clinic

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

Alegent Health Mercy Hospital

Council Bluffs, Iowa, 51503

Suspended

Greater Regional Medical Center

Creston, Iowa, 50801

Recruiting
Site Public Contact · Contact
515-241-3305
Richard L. Deming · Principal Investigator

Iowa Methodist Medical Center

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
515-241-6727
Seema Harichand-Herdt · Principal Investigator

UI Health Care Mission Cancer and Blood - Des Moines Clinic

Des Moines, Iowa, 50309

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

Broadlawns Medical Center

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
515-282-2200
Seema Harichand-Herdt · Principal Investigator

Mercy Medical Center - Des Moines

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
515-241-3305
Richard L. Deming · Principal Investigator

UI Health Care Mission Cancer and Blood - Laurel Clinic

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

Iowa Lutheran Hospital

Des Moines, Iowa, 50316

Recruiting
Site Public Contact · Contact
515-241-8704
Seema Harichand-Herdt · Principal Investigator

McFarland Clinic - Trinity Cancer Center

Fort Dodge, Iowa, 50501

Recruiting
Site Public Contact · Contact
515-956-4132
Joseph J. Merchant · Principal Investigator

UI Healthcare Mission Cancer and Blood - Fort Dodge

Fort Dodge, Iowa, 50501

Recruiting
Site Public Contact · Contact
515-282-2921trials@missioncancer.com
Seema Harichand-Herdt · Principal Investigator

McFarland Clinic - Jefferson

Jefferson, Iowa, 50129

Suspended

McFarland Clinic - Marshalltown

Marshalltown, Iowa, 50158

Recruiting
Site Public Contact · Contact
515-956-4132
Joseph J. Merchant · Principal Investigator

Siouxland Regional Cancer Center

Sioux City, Iowa, 51101

Active Not Recruiting

UI Health Care Mission Cancer and Blood - Waukee Clinic

Waukee, Iowa, 50263

Recruiting
Site Public Contact · Contact
515-241-3305
Seema Harichand-Herdt · Principal Investigator

Methodist West Hospital

West Des Moines, Iowa, 50266-7700

Recruiting
Site Public Contact · Contact
515-343-1000
Seema Harichand-Herdt · Principal Investigator

Mercy Medical Center-West Lakes

West Des Moines, Iowa, 50266

Recruiting
Site Public Contact · Contact
515-241-3305
Richard L. Deming · Principal Investigator

Cancer Center of Kansas - Chanute

Chanute, Kansas, 66720

Suspended

Cancer Center of Kansas - Dodge City

Dodge City, Kansas, 67801

Suspended

Cancer Center of Kansas - El Dorado

El Dorado, Kansas, 67042

Suspended

Central Care Cancer Center - Garden City

Garden City, Kansas, 67846

Recruiting
Site Public Contact · Contact
913-948-5588aroland@kccop.org
Jay W. Carlson · Principal Investigator

Central Care Cancer Center - Great Bend

Great Bend, Kansas, 67530

Recruiting
Site Public Contact · Contact
913-948-5588aroland@kccop.org
Jay W. Carlson · Principal Investigator

Cancer Center of Kansas-Independence

Independence, Kansas, 67301

Suspended

Cancer Center of Kansas-Kingman

Kingman, Kansas, 67068

Suspended

Cancer Center of Kansas-Liberal

Liberal, Kansas, 67905

Suspended

Cancer Center of Kansas-Manhattan

Manhattan, Kansas, 66502

Suspended

Cancer Center of Kansas - McPherson

McPherson, Kansas, 67460

Suspended

Cancer Center of Kansas - Newton

Newton, Kansas, 67114

Suspended

Cancer Center of Kansas - Parsons

Parsons, Kansas, 67357

Suspended

Mercy Hospital Pittsburg

Pittsburg, Kansas, 66762

Recruiting
Site Public Contact · Contact
888-446-3729
Jay W. Carlson · Principal Investigator

Cancer Center of Kansas - Pratt

Pratt, Kansas, 67124

Suspended

Cancer Center of Kansas - Salina

Salina, Kansas, 67401

Suspended

Cancer Center of Kansas - Wellington

Wellington, Kansas, 67152

Suspended

Cancer Center of Kansas-Wichita Medical Arts Tower

Wichita, Kansas, 67208

Suspended

Ascension Via Christi Hospitals Wichita

Wichita, Kansas, 67214

Suspended

Cancer Center of Kansas - Wichita

Wichita, Kansas, 67214

Suspended

Cancer Center of Kansas - Winfield

Winfield, Kansas, 67156

Suspended

Flaget Memorial Hospital

Bardstown, Kentucky, 40004

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Commonwealth Cancer Center-Corbin

Corbin, Kentucky, 40701

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Saint Joseph Hospital

Lexington, Kentucky, 40504

Suspended

Saint Joseph Radiation Oncology Resource Center

Lexington, Kentucky, 40504

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Saint Joseph Hospital East

Lexington, Kentucky, 40509

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Saint Joseph London

London, Kentucky, 40741

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Jewish Hospital

Louisville, Kentucky, 40202

Suspended

Saints Mary and Elizabeth Hospital

Louisville, Kentucky, 40215

Suspended

UofL Health Medical Center Northeast

Louisville, Kentucky, 40245

Suspended

Saint Joseph Mount Sterling

Mount Sterling, Kentucky, 40353

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Jewish Hospital Medical Center South

Shepherdsville, Kentucky, 40165

Suspended

LSU Health Baton Rouge-North Clinic

Baton Rouge, Louisiana, 70805

Suspended

Our Lady of the Lake Physician Group

Baton Rouge, Louisiana, 70808

Suspended

Ochsner LSU Health Monroe Medical Center

Monroe, Louisiana, 71202

Suspended

LSU Health Sciences Center at Shreveport

Shreveport, Louisiana, 71103

Suspended

Christiana Care - Union Hospital

Elkton, Maryland, 21921

Active Not Recruiting

Frederick Memorial Hospital

Frederick, Maryland, 21701

Active Not Recruiting

FMH James M Stockman Cancer Institute

Frederick, Maryland, 21702

Active Not Recruiting

Tufts Medical Center

Boston, Massachusetts, 02111

Recruiting
Site Public Contact · Contact
617-636-5000ContactUsCancerCenter@TuftsMedicalCenter.org
Raymond L. Comenzo · Principal Investigator

Tufts Medical Center Cancer Center Stoneham

Stoneham, Massachusetts, 02180

Recruiting
Site Public Contact · Contact
617-636-3264NCCCR@Tuftsmedicalcenter.org
Raymond L. Comenzo · Principal Investigator

Hickman Cancer Center

Adrian, Michigan, 49221

Suspended

MyMichigan Medical Center Gratiot

Alma, Michigan, 48801

Recruiting
Site Public Contact · Contact
989-631-2469CVResearch@mymichigan.org
Elie G. Dib · Principal Investigator

MyMichigan Medical Center Alpena

Alpena, Michigan, 49707

Recruiting
Site Public Contact · Contact
989-631-2469CVResearch@mymichigan.org
Elie G. Dib · Principal Investigator

Trinity Health Saint Joseph Mercy Hospital Ann Arbor

Ann Arbor, Michigan, 48106

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Bronson Battle Creek

Battle Creek, Michigan, 49017

Suspended

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, 48114

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Trinity Health Medical Center - Brighton

Brighton, Michigan, 48114

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, 48188

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Trinity Health Medical Center - Canton

Canton, Michigan, 48188

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Caro Cancer Center

Caro, Michigan, 48723

Suspended

Chelsea Hospital

Chelsea, Michigan, 48118

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, 48118

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Hematology Oncology Consultants-Clarkston

Clarkston, Michigan, 48346

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Newland Medical Associates-Clarkston

Clarkston, Michigan, 48346

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Henry Ford Hospital

Detroit, Michigan, 48202

Suspended

Henry Ford Health Saint John Hospital

Detroit, Michigan, 48236

Recruiting
Site Public Contact · Contact
313-343-3166Kkeenan1@hfhs.org
Elie G. Dib · Principal Investigator

Henry Ford River District Hospital

East China, Michigan, 48054

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

OSF Saint Francis Hospital and Medical Group

Escanaba, Michigan, 49829

Recruiting
Site Public Contact · Contact
920-433-8889WI_research_admin@hshs.org
Brian L. Burnette · Principal Investigator

Cancer Hematology Centers - Flint

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
810-762-8038wstrong@ghci.org
Elie G. Dib · Principal Investigator

Genesee Hematology Oncology PC

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
810-762-8038wstrong@ghci.org
Elie G. Dib · Principal Investigator

Genesys Hurley Cancer Institute

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
810-762-8038wstrong@ghci.org
Elie G. Dib · Principal Investigator

Hurley Medical Center

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
810-762-8038wstrong@ghci.org
Elie G. Dib · Principal Investigator

MyMichigan Medical Center Gladwin

Gladwin, Michigan, 48624

Recruiting
Site Public Contact · Contact
989-631-2469CVResearch@mymichigan.org
Elie G. Dib · Principal Investigator

Corewell Health Grand Rapids Hospitals - Butterworth Hospital

Grand Rapids, Michigan, 49503

Suspended

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital

Grand Rapids, Michigan, 49503

Suspended

Trinity Health Grand Rapids Hospital

Grand Rapids, Michigan, 49503

Suspended

Henry Ford Saint John Hospital - Academic

Grosse Pointe Woods, Michigan, 48236

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Henry Ford Saint John Hospital - Breast

Grosse Pointe Woods, Michigan, 48236

Recruiting
Site Public Contact · Contact
313-343-3166karen.forman@ascension.org
Elie G. Dib · Principal Investigator

Henry Ford Saint John Hospital - Van Elslander

Grosse Pointe Woods, Michigan, 48236

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007

Suspended

West Michigan Cancer Center

Kalamazoo, Michigan, 49007

Suspended

Beacon Kalamazoo Cancer Center

Kalamazoo, Michigan, 49009

Suspended

Beacon Kalamazoo

Kalamazoo, Michigan, 49048

Suspended

University of Michigan Health - Sparrow Lansing

Lansing, Michigan, 48912

Recruiting
Site Public Contact · Contact
517-364-3712harsha.trivedi@umhsparrow.org
Elie G. Dib · Principal Investigator

Hope Cancer Clinic

Livonia, Michigan, 48154

Suspended

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, 48154

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Henry Ford Saint John Hospital - Macomb Medical

Macomb, Michigan, 48044

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Henry Ford Warren Hospital - Breast Macomb

Macomb, Michigan, 48044

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Saint Mary's Oncology/Hematology Associates of Marlette

Marlette, Michigan, 48453

Suspended

MyMichigan Medical Center Midland

Midland, Michigan, 48670

Recruiting
Site Public Contact · Contact
989-631-2469CVResearch@mymichigan.org
Elie G. Dib · Principal Investigator

Toledo Clinic Cancer Centers-Monroe

Monroe, Michigan, 48162

Suspended

MyMichigan Medical Center Mount Pleasant

Mount Pleasant, Michigan, 48858

Recruiting
Site Public Contact · Contact
989-631-2469CVResearch@mymichigan.org
Elie G. Dib · Principal Investigator

Trinity Health Muskegon Hospital

Muskegon, Michigan, 49444

Suspended

Corewell Health Lakeland Hospitals - Niles Hospital

Niles, Michigan, 49120

Suspended

Cancer and Hematology Centers of Western Michigan - Norton Shores

Norton Shores, Michigan, 49444

Suspended

Henry Ford Health Providence Novi Hospital

Novi, Michigan, 48374

Suspended

Hope Cancer Center

Pontiac, Michigan, 48341

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Michigan Healthcare Professionals Pontiac

Pontiac, Michigan, 48341

Recruiting
Site Public Contact · Contact
248-858-6215Emily.Crofts@trinity-health.org
Elie G. Dib · Principal Investigator

Newland Medical Associates-Pontiac

Pontiac, Michigan, 48341

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Trinity Health Saint Joseph Mercy Oakland Hospital

Pontiac, Michigan, 48341

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Corewell Health Reed City Hospital

Reed City, Michigan, 49677

Suspended

Henry Ford Rochester Hospital

Rochester Hills, Michigan, 48309

Suspended

MyMichigan Medical Center Saginaw

Saginaw, Michigan, 48601

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Oncology Hematology Associates of Saginaw Valley PC

Saginaw, Michigan, 48604

Suspended

Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center

Saint Joseph, Michigan, 49085

Suspended

Corewell Health Lakeland Hospitals - Saint Joseph Hospital

Saint Joseph, Michigan, 49085

Suspended

Henry Ford Health Providence Southfield Hospital

Southfield, Michigan, 48075

Suspended

Bhadresh Nayak MD PC-Sterling Heights

Sterling Heights, Michigan, 48312

Suspended

MyMichigan Medical Center Tawas

Tawas City, Michigan, 48764

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Munson Medical Center

Traverse City, Michigan, 49684

Suspended

Advanced Breast Care Center PLLC

Warren, Michigan, 48088

Suspended

Henry Ford Health Warren Hospital

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Henry Ford Madison Heights Hospital - Breast

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Henry Ford Warren Hospital - GLCMS

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
313-343-3166kforman1@hfhs.org
Elie G. Dib · Principal Investigator

Macomb Hematology Oncology PC

Warren, Michigan, 48093

Suspended

Saint Mary's Oncology/Hematology Associates of West Branch

West Branch, Michigan, 48661

Suspended

University of Michigan Health - West

Wyoming, Michigan, 49519

Suspended

Huron Gastroenterology PC

Ypsilanti, Michigan, 48106

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, 48197

Recruiting
Site Public Contact · Contact
734-712-7251MCRCwebsitecontactform@stjoeshealth.org
Elie G. Dib · Principal Investigator

Sanford Joe Lueken Cancer Center

Bemidji, Minnesota, 56601

Suspended

Fairview Ridges Hospital

Burnsville, Minnesota, 55337

Suspended

Minnesota Oncology - Burnsville

Burnsville, Minnesota, 55337

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Cambridge Medical Center

Cambridge, Minnesota, 55008

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology Hematology PA-Chaska

Chaska, Minnesota, 55318

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Mercy Hospital

Coon Rapids, Minnesota, 55433

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology - Coon Rapids

Coon Rapids, Minnesota, 55433

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Fairview Southdale Hospital

Edina, Minnesota, 55435

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology - Edina

Edina, Minnesota, 55435

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Unity Hospital

Fridley, Minnesota, 55432

Active Not Recruiting

Fairview Clinics and Surgery Center Maple Grove

Maple Grove, Minnesota, 55369

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology - Maple Grove

Maple Grove, Minnesota, 55369

Recruiting
Site Public Contact · Contact
952-993-1572mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology Hematology PA-Maplewood

Maplewood, Minnesota, 55109

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Saint John's Hospital - Healtheast

Maplewood, Minnesota, 55109

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Abbott-Northwestern Hospital

Minneapolis, Minnesota, 55407

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Hennepin County Medical Center

Minneapolis, Minnesota, 55415

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Health Partners Inc

Minneapolis, Minnesota, 55454

Suspended

Monticello Cancer Center

Monticello, Minnesota, 55362

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

New Ulm Medical Center

New Ulm, Minnesota, 56073

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Fairview Northland Medical Center

Princeton, Minnesota, 55371

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

North Memorial Medical Health Center

Robbinsdale, Minnesota, 55422

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

Recruiting
Site Public Contact · Contact
855-776-0015
Shaji K. Kumar · Principal Investigator

Coborn Cancer Center at Saint Cloud Hospital

Saint Cloud, Minnesota, 56303

Suspended

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, 55416

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Regions Hospital

Saint Paul, Minnesota, 55101

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

United Hospital

Saint Paul, Minnesota, 55102

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Saint Francis Regional Medical Center

Shakopee, Minnesota, 55379

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Lakeview Hospital

Stillwater, Minnesota, 55082

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Sanford Thief River Falls Medical Center

Thief River Falls, Minnesota, 56701

Suspended

Ridgeview Medical Center

Waconia, Minnesota, 55387

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Rice Memorial Hospital

Willmar, Minnesota, 56201

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Minnesota Oncology Hematology PA-Woodbury

Woodbury, Minnesota, 55125

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Fairview Lakes Medical Center

Wyoming, Minnesota, 55092

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

Gulfport Memorial Hospital

Gulfport, Mississippi, 39502

Suspended

Mercy Oncology and Hematology - Clayton-Clarkson

Ballwin, Missouri, 63011

Recruiting
Site Public Contact · Contact
888-446-3729
Jay W. Carlson · Principal Investigator

Central Care Cancer Center - Bolivar

Bolivar, Missouri, 65613

Recruiting
Site Public Contact · Contact
913-948-5588aroland@kccop.org
Jay W. Carlson · Principal Investigator

Cox Cancer Center Branson

Branson, Missouri, 65616

Recruiting
Site Public Contact · Contact
417-269-4520
Jay W. Carlson · Principal Investigator

Mercy Cancer Center - Cape Girardeau

Cape Girardeau, Missouri, 63703

Recruiting
Site Public Contact · Contact
888-446-3729
Jay W. Carlson · Principal Investigator

Saint Francis Medical Center

Cape Girardeau, Missouri, 63703

Recruiting
Site Public Contact · Contact
573-334-2230sfmc@sfmc.net
Bryan A. Faller · Principal Investigator

Saint Luke's Hospital

Chesterfield, Missouri, 63017

Suspended

Parkland Health Center - Farmington

Farmington, Missouri, 63640

Recruiting
Site Public Contact · Contact
314-996-5569
Bryan A. Faller · Principal Investigator

MU Health Care Goldschmidt Cancer Center

Jefferson City, Missouri, 65109

Suspended

Freeman Health System

Joplin, Missouri, 64804

Recruiting
Site Public Contact · Contact
417-347-4030LJCrockett@freemanhealth.com
Jay W. Carlson · Principal Investigator

Mercy Hospital Joplin

Joplin, Missouri, 64804

Recruiting
Site Public Contact · Contact
417-556-3074esmeralda.carrillo@mercy.net
Jay W. Carlson · Principal Investigator

Kansas City Veterans Affairs Medical Center

Kansas City, Missouri, 64128

Suspended

Lake Regional Hospital

Osage Beach, Missouri, 65065

Recruiting
Site Public Contact · Contact
573-302-2768clinicaltrials@lakeregional.com
Jay W. Carlson · Principal Investigator

Mercy Clinic-Rolla-Cancer and Hematology

Rolla, Missouri, 65401

Recruiting
Site Public Contact · Contact
573-458-6379
Jay W. Carlson · Principal Investigator

Phelps Health Delbert Day Cancer Institute

Rolla, Missouri, 65401

Recruiting
Site Public Contact · Contact
573-458-7504research@phelpshealth.org
Jay W. Carlson · Principal Investigator

Heartland Regional Medical Center

Saint Joseph, Missouri, 64506

Recruiting
Site Public Contact · Contact
816-271-7937Trisha.England2@mymlc.com
Jay W. Carlson · Principal Investigator

Sainte Genevieve County Memorial Hospital

Sainte Genevieve, Missouri, 63670

Recruiting
Site Public Contact · Contact
314-996-5569
Bryan A. Faller · Principal Investigator

Mercy Hospital Springfield

Springfield, Missouri, 65804

Recruiting
Site Public Contact · Contact
417-269-4520
Jay W. Carlson · Principal Investigator

CoxHealth South Hospital

Springfield, Missouri, 65807

Recruiting
Site Public Contact · Contact
417-269-4520
Jay W. Carlson · Principal Investigator

Mercy Infusion Center - Chippewa

St Louis, Missouri, 63109

Recruiting
Site Public Contact · Contact
888-446-3729
Jay W. Carlson · Principal Investigator

Mercy Hospital South

St Louis, Missouri, 63128

Recruiting
Site Public Contact · Contact
314-525-6042Danielle.Werle@mercy.net
Jay W. Carlson · Principal Investigator

Missouri Baptist Medical Center

St Louis, Missouri, 63131

Recruiting
Site Public Contact · Contact
314-996-5569
Bryan A. Faller · Principal Investigator

Mercy Hospital Saint Louis

St Louis, Missouri, 63141

Recruiting
Site Public Contact · Contact
314-251-7066
Jay W. Carlson · Principal Investigator

Missouri Baptist Sullivan Hospital

Sullivan, Missouri, 63080

Recruiting
Site Public Contact · Contact
314-996-5569
Bryan A. Faller · Principal Investigator

BJC Outpatient Center at Sunset Hills

Sunset Hills, Missouri, 63127

Recruiting
Site Public Contact · Contact
314-996-5569
Bryan A. Faller · Principal Investigator

Mercy Hospital Washington

Washington, Missouri, 63090

Recruiting
Site Public Contact · Contact
636-390-1600
Jay W. Carlson · Principal Investigator

Community Hospital of Anaconda

Anaconda, Montana, 59711

Suspended

Billings Clinic Cancer Center

Billings, Montana, 59101

Suspended

Bozeman Health Deaconess Hospital

Bozeman, Montana, 59715

Suspended

Benefis Sletten Cancer Institute

Great Falls, Montana, 59405

Suspended

Great Falls Clinic

Great Falls, Montana, 59405

Suspended

Hi-Line Sletten Cancer Center

Havre, Montana, 59501

Suspended

Benefis Helena Specialty Center

Helena, Montana, 59601

Suspended

Logan Health Medical Center

Kalispell, Montana, 59901

Suspended

Saint Patrick Hospital - Community Hospital

Missoula, Montana, 59802

Suspended

Community Medical Center

Missoula, Montana, 59804

Suspended

CHI Health Saint Francis

Grand Island, Nebraska, 68803

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Nebraska Cancer Specialists/Oncology Hematology West PC

Grand Island, Nebraska, 68803

Suspended

CHI Health Good Samaritan

Kearney, Nebraska, 68847

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Saint Elizabeth Regional Medical Center

Lincoln, Nebraska, 68510

Suspended

Cancer Partners of Nebraska

Lincoln, Nebraska, 68516

Active Not Recruiting

Alegent Health Immanuel Medical Center

Omaha, Nebraska, 68122

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Alegent Health Bergan Mercy Medical Center

Omaha, Nebraska, 68124

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Alegent Health Lakeside Hospital

Omaha, Nebraska, 68130

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Creighton University Medical Center

Omaha, Nebraska, 68131

Suspended

Midlands Community Hospital

Papillion, Nebraska, 68046

Suspended

Jefferson Cherry Hill Hospital

Cherry Hill, New Jersey, 08002

Suspended

Englewood Hospital and Medical Center

Englewood, New Jersey, 07631

Suspended

Morristown Medical Center

Morristown, New Jersey, 07960

Suspended

Sidney Kimmel Cancer Center Washington Township

Sewell, New Jersey, 08080

Suspended

Overlook Hospital

Summit, New Jersey, 07902

Suspended

University of New Mexico Cancer Center

Albuquerque, New Mexico, 87106

Suspended

Hematology Oncology Associates of Central New York-Auburn

Auburn, New York, 13021

Suspended

Lourdes Hospital

Binghamton, New York, 13905

Suspended

Hematology Oncology Associates of CNY at Camillus

Camillus, New York, 13031

Suspended

Hematology Oncology Associates of Central New York-East Syracuse

East Syracuse, New York, 13057

Suspended

Glens Falls Hospital

Glens Falls, New York, 12801

Suspended

University of Rochester

Rochester, New York, 14642

Recruiting
Site Public Contact · Contact
585-275-5830
Brea C. Lipe · Principal Investigator

Stony Brook University Medical Center

Stony Brook, New York, 11794

Active Not Recruiting

State University of New York Upstate Medical University

Syracuse, New York, 13210

Suspended

Upstate Cancer Center at Verona

Verona, New York, 13478

Suspended

Good Samaritan University Hospital

West Islip, New York, 11795

Active Not Recruiting

Southeastern Medical Oncology Center-Clinton

Clinton, North Carolina, 28328

Recruiting
Site Public Contact · Contact
919-587-9084jfields@cancersmoc.com
Samer S. Kasbari · Principal Investigator

Southeastern Medical Oncology Center-Goldsboro

Goldsboro, North Carolina, 27534

Recruiting
Site Public Contact · Contact
919-587-9084jfields@cancersmoc.com
Samer S. Kasbari · Principal Investigator

East Carolina University

Greenville, North Carolina, 27834

Suspended

Southeastern Medical Oncology Center-Jacksonville

Jacksonville, North Carolina, 28546

Recruiting
Site Public Contact · Contact
910-587-9084jfields@cancersmoc.com
Samer S. Kasbari · Principal Investigator

ECU Health Oncology Kenansville

Kenansville, North Carolina, 28349

Active Not Recruiting

ECU Health Oncology Kinston

Kinston, North Carolina, 28501

Active Not Recruiting

ECU Health Oncology Richlands

Richlands, North Carolina, 28574

Active Not Recruiting

Sanford Bismarck Medical Center

Bismarck, North Dakota, 58501

Suspended

Sanford South University Medical Center

Fargo, North Dakota, 58103

Suspended

Southpointe-Sanford Medical Center Fargo

Fargo, North Dakota, 58103

Suspended

Sanford Medical Center Fargo

Fargo, North Dakota, 58104

Suspended

Sanford Broadway Medical Center

Fargo, North Dakota, 58122

Suspended

Sanford Roger Maris Cancer Center

Fargo, North Dakota, 58122

Suspended

OhioHealth O'Bleness Hospital

Athens, Ohio, 45701

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

UHHS-Chagrin Highlands Medical Center

Beachwood, Ohio, 44122

Active Not Recruiting

Indu and Raj Soin Medical Center

Beavercreek, Ohio, 45431

Suspended

Strecker Cancer Center-Belpre

Belpre, Ohio, 45714

Suspended

Saint Elizabeth Boardman Hospital

Boardman, Ohio, 44512

Suspended

Dayton Physicians LLC-Miami Valley South

Centerville, Ohio, 45459

Suspended

Miami Valley Hospital South

Centerville, Ohio, 45459

Suspended

Geauga Hospital

Chardon, Ohio, 44024

Active Not Recruiting

Adena Regional Medical Center

Chillicothe, Ohio, 45601

Suspended

University of Cincinnati Cancer Center-UC Medical Center

Cincinnati, Ohio, 45219

Suspended

Good Samaritan Hospital - Cincinnati

Cincinnati, Ohio, 45220

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Oncology Hematology Care Inc-Kenwood

Cincinnati, Ohio, 45236

Suspended

Bethesda North Hospital

Cincinnati, Ohio, 45242

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

TriHealth Cancer Institute-Westside

Cincinnati, Ohio, 45247

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

TriHealth Cancer Institute-Anderson

Cincinnati, Ohio, 45255

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Case Western Reserve University

Cleveland, Ohio, 44106

Active Not Recruiting

Louis Stokes Cleveland VA Medical Center

Cleveland, Ohio, 44106

Suspended

MetroHealth Medical Center

Cleveland, Ohio, 44109

Recruiting
Site Public Contact · Contact
216-778-7559ababal@metrohealth.org
Tamila L. Kindwall-Keller · Principal Investigator

Mount Carmel East Hospital

Columbus, Ohio, 43213

Suspended

Columbus Oncology and Hematology Associates Inc

Columbus, Ohio, 43214

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Riverside Methodist Hospital

Columbus, Ohio, 43214

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Grant Medical Center

Columbus, Ohio, 43215

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

The Mark H Zangmeister Center

Columbus, Ohio, 43219

Suspended

Mount Carmel Health Center West

Columbus, Ohio, 43222

Suspended

Doctors Hospital

Columbus, Ohio, 43228

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Miami Valley Hospital

Dayton, Ohio, 45409

Suspended

Premier Blood and Cancer Center

Dayton, Ohio, 45409

Suspended

Dayton Physician LLC - Englewood

Dayton, Ohio, 45415

Suspended

Miami Valley Hospital North

Dayton, Ohio, 45415

Suspended

Delaware Health Center-Grady Cancer Center

Delaware, Ohio, 43015

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Grady Memorial Hospital

Delaware, Ohio, 43015

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Columbus Oncology and Hematology Associates

Dublin, Ohio, 43016

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Dublin Methodist Hospital

Dublin, Ohio, 43016

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Armes Family Cancer Center

Findlay, Ohio, 45840

Suspended

Blanchard Valley Hospital

Findlay, Ohio, 45840

Suspended

Orion Cancer Care

Findlay, Ohio, 45840

Suspended

Atrium Medical Center-Middletown Regional Hospital

Franklin, Ohio, 45005-1066

Suspended

Dayton Physicians LLC-Atrium

Franklin, Ohio, 45005

Suspended

Central Ohio Breast and Endocrine Surgery

Gahanna, Ohio, 43230

Suspended

Dayton Physicians LLC-Wayne

Greenville, Ohio, 45331

Suspended

Miami Valley Cancer Care and Infusion

Greenville, Ohio, 45331

Suspended

Wayne Hospital

Greenville, Ohio, 45331

Suspended

Mount Carmel Grove City Hospital

Grove City, Ohio, 43123

Suspended

Zangmeister Center Grove City

Grove City, Ohio, 43123

Suspended

Greater Dayton Cancer Center

Kettering, Ohio, 45409

Suspended

Kettering Medical Center

Kettering, Ohio, 45429

Suspended

Fairfield Medical Center

Lancaster, Ohio, 43130

Suspended

Saint Rita's Medical Center

Lima, Ohio, 45801

Suspended

OhioHealth Mansfield Hospital

Mansfield, Ohio, 44903

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Marietta Memorial Hospital

Marietta, Ohio, 45750

Suspended

OhioHealth Marion General Hospital

Marion, Ohio, 43302

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Memorial Hospital

Marysville, Ohio, 43040

Suspended

Toledo Clinic Cancer Centers-Maumee

Maumee, Ohio, 43537

Suspended

UH Seidman Cancer Center at Landerbrook Health Center

Mayfield Heights, Ohio, 44124

Active Not Recruiting

Knox Community Hospital

Mount Vernon, Ohio, 43050

Suspended

Mount Carmel New Albany Surgical Hospital

New Albany, Ohio, 43054

Suspended

Licking Memorial Hospital

Newark, Ohio, 43055

Suspended

Newark Radiation Oncology

Newark, Ohio, 43055

Suspended

University Hospitals Parma Medical Center

Parma, Ohio, 44129

Active Not Recruiting

Mercy Health - Perrysburg Hospital

Perrysburg, Ohio, 43551

Suspended

OhioHealth Pickerington Methodist Hospital

Pickerington, Ohio, 43147

Recruiting
Site Public Contact · Contact
614-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

Southern Ohio Medical Center

Portsmouth, Ohio, 45662

Suspended

Springfield Regional Cancer Center

Springfield, Ohio, 45504

Suspended

Springfield Regional Medical Center

Springfield, Ohio, 45504

Suspended

Mercy Health - Saint Vincent Hospital

Toledo, Ohio, 43608

Suspended

Mercy Health - Saint Anne Hospital

Toledo, Ohio, 43623

Suspended

Mercy Health Sylvania Radiation Oncology Center

Toledo, Ohio, 43623

Suspended

Toledo Clinic Cancer Centers-Toledo

Toledo, Ohio, 43623

Suspended

Dayton Physicians LLC - Troy

Troy, Ohio, 45373

Suspended

Upper Valley Medical Center

Troy, Ohio, 45373

Suspended

University Hospitals Sharon Health Center

Wadsworth, Ohio, 44281

Active Not Recruiting

Saint Joseph Warren Hospital

Warren, Ohio, 44484

Suspended

University of Cincinnati Cancer Center-West Chester

West Chester, Ohio, 45069

Suspended

Saint Ann's Hospital

Westerville, Ohio, 43081

Suspended

OhioHealth Westerville Medical Campus/Westerville Cancer Center

Westerville, Ohio, 43082

Recruiting
Site Public Contact · Contact
610-788-3860Jennifer.Sexton@ohiohealth.com
Yvonne A. Efebera · Principal Investigator

UH Seidman Cancer Center at Saint John Medical Center

Westlake, Ohio, 44145

Active Not Recruiting

Clinton Memorial Hospital/Foster J Boyd Regional Cancer Center

Wilmington, Ohio, 45177

Suspended

Saint Elizabeth Youngstown Hospital

Youngstown, Ohio, 44501

Suspended

Genesis Healthcare System Cancer Care Center

Zanesville, Ohio, 43701

Suspended

Mercy Hospital Oklahoma City

Oklahoma City, Oklahoma, 73120

Recruiting
Site Public Contact · Contact
405-752-3402
Jay W. Carlson · Principal Investigator

Saint Alphonsus Cancer Care Center-Baker City

Baker City, Oregon, 97814

Recruiting
Site Public Contact · Contact
406-969-6060mccinfo@mtcancer.org
Elie G. Dib · Principal Investigator

Saint Charles Health System

Bend, Oregon, 97701

Suspended

Clackamas Radiation Oncology Center

Clackamas, Oregon, 97015

Suspended

Providence Cancer Institute Clackamas Clinic

Clackamas, Oregon, 97015

Suspended

Bay Area Hospital

Coos Bay, Oregon, 97420

Suspended

Providence Hood River Memorial Hospital

Hood River, Oregon, 97031

Suspended

Providence Newberg Medical Center

Newberg, Oregon, 97132

Suspended

Saint Alphonsus Cancer Care Center-Ontario

Ontario, Oregon, 97914

Recruiting
Site Public Contact · Contact
406-969-6060mccinfo@mtcancer.org
Elie G. Dib · Principal Investigator

Providence Willamette Falls Medical Center

Oregon City, Oregon, 97045

Suspended

Providence Portland Medical Center

Portland, Oregon, 97213

Suspended

Providence Saint Vincent Medical Center

Portland, Oregon, 97225

Suspended

Oregon Health and Science University

Portland, Oregon, 97239

Suspended

Saint Charles Health System-Redmond

Redmond, Oregon, 97756

Suspended

Lehigh Valley Hospital-Cedar Crest

Allentown, Pennsylvania, 18103

Recruiting
Site Public Contact · Contact
610-402-9543Morgan_M.Horton@lvhn.org
Elie G. Dib · Principal Investigator

Lehigh Valley Hospital - Muhlenberg

Bethlehem, Pennsylvania, 18017

Recruiting
Site Public Contact · Contact
610-402-9543Morgan_M.Horton@lvhn.org
Elie G. Dib · Principal Investigator

Christiana Care Health System-Concord Health Center

Chadds Ford, Pennsylvania, 19317

Active Not Recruiting

Geisinger Medical Center

Danville, Pennsylvania, 17822

Suspended

Geisinger Cancer Center Dickson City

Dickson City, Pennsylvania, 18519

Suspended

Pocono Medical Center

East Stroudsburg, Pennsylvania, 18301

Recruiting
Site Public Contact · Contact
610-402-9543Morgan_M.Horton@lvhn.org
Elie G. Dib · Principal Investigator

Penn State Health Medical Group - Andrews Patel Hematology/Oncology East

Harrisburg, Pennsylvania, 17111

Recruiting
Site Public Contact · Contact
717-526-1030
Kevin Rakszawski · Principal Investigator

Geisinger Medical Center-Cancer Center Hazleton

Hazleton, Pennsylvania, 18201

Suspended

Lehigh Valley Hospital-Hazleton

Hazleton, Pennsylvania, 18201

Recruiting
Site Public Contact · Contact
610-402-9543Morgan_M.Horton@lvhn.org
Elie G. Dib · Principal Investigator

Penn State Milton S Hershey Medical Center

Hershey, Pennsylvania, 17033-0850

Suspended

Geisinger Medical Oncology-Lewisburg

Lewisburg, Pennsylvania, 17837

Suspended

Thomas Jefferson University Hospital

Philadelphia, Pennsylvania, 19107

Suspended

Geisinger Cancer Services-Pottsville

Pottsville, Pennsylvania, 17901

Suspended

Penn State Health Saint Joseph Medical Center

Reading, Pennsylvania, 19605

Recruiting
Site Public Contact · Contact
610-378-2336dward1@pennstatehealth.psu.edu
Kevin Rakszawski · Principal Investigator

Community Medical Center

Scranton, Pennsylvania, 18510

Suspended

Reading Hospital

West Reading, Pennsylvania, 19611

Suspended

Geisinger Wyoming Valley/Henry Cancer Center

Wilkes-Barre, Pennsylvania, 18711

Suspended

Smilow Cancer Hospital Care Center - Westerly

Westerly, Rhode Island, 02891

Suspended

Ralph H Johnson VA Medical Center

Charleston, South Carolina, 29401

Recruiting
Site Public Contact · Contact
843-789-7020ashley.salvo@va.gov
Oleksandra Lupak · Principal Investigator

Medical University of South Carolina

Charleston, South Carolina, 29425

Suspended

Saint Francis Hospital

Greenville, South Carolina, 29601

Active Not Recruiting

Saint Francis Cancer Center

Greenville, South Carolina, 29607

Active Not Recruiting

Rapid City Regional Hospital

Rapid City, South Dakota, 57701

Suspended

Avera Cancer Institute

Sioux Falls, South Dakota, 57105

Active Not Recruiting

Vanderbilt University/Ingram Cancer Center

Nashville, Tennessee, 37232

Suspended

Saint Joseph Regional Cancer Center

Bryan, Texas, 77802

Suspended

Huntsman Cancer Institute/University of Utah

Salt Lake City, Utah, 84112

Suspended

University of Vermont Medical Center

Burlington, Vermont, 05401

Suspended

University of Vermont and State Agricultural College

Burlington, Vermont, 05405

Suspended

White River Junction Veteran Administration Medical Center

White River Junction, Vermont, 05009

Recruiting
Site Public Contact · Contact
866-687-8387
Britt H. Olmsted · Principal Investigator

University of Virginia Cancer Center

Charlottesville, Virginia, 22908

Suspended

Inova Schar Cancer Institute

Fairfax, Virginia, 22031

Active Not Recruiting

Inova Fairfax Hospital

Falls Church, Virginia, 22042

Active Not Recruiting

Centra Alan B Pearson Regional Cancer Center

Lynchburg, Virginia, 24501

Suspended

Virginia Cancer Institute

Richmond, Virginia, 23229

Suspended

VCU Massey Comprehensive Cancer Center

Richmond, Virginia, 23298

Suspended

VCU Community Memorial Health Center

South Hill, Virginia, 23970

Suspended

Providence Regional Cancer System-Aberdeen

Aberdeen, Washington, 98520

Suspended

PeaceHealth Saint Joseph Medical Center

Bellingham, Washington, 98225

Suspended

Highline Medical Center-Main Campus

Burien, Washington, 98166

Suspended

Providence Regional Cancer System-Centralia

Centralia, Washington, 98531

Suspended

Swedish Cancer Institute-Edmonds

Edmonds, Washington, 98026

Suspended

Saint Elizabeth Hospital

Enumclaw, Washington, 98022

Suspended

Providence Regional Cancer Partnership

Everett, Washington, 98201

Suspended

Saint Francis Hospital

Federal Way, Washington, 98003

Suspended

Swedish Cancer Institute-Issaquah

Issaquah, Washington, 98029

Suspended

Kadlec Clinic Hematology and Oncology

Kennewick, Washington, 99336

Suspended

Providence Regional Cancer System-Lacey

Lacey, Washington, 98503

Suspended

Saint Clare Hospital

Lakewood, Washington, 98499

Suspended

PeaceHealth Saint John Medical Center

Longview, Washington, 98632

Suspended

Skagit Regional Health Cancer Care Center

Mount Vernon, Washington, 98274

Suspended

Harrison HealthPartners Hematology and Oncology-Poulsbo

Poulsbo, Washington, 98370

Active Not Recruiting

Pacific Gynecology Specialists

Seattle, Washington, 98104

Suspended

Swedish Medical Center-Ballard Campus

Seattle, Washington, 98107

Suspended

Swedish Medical Center-Cherry Hill

Seattle, Washington, 98122-5711

Suspended

Swedish Medical Center-First Hill

Seattle, Washington, 98122

Suspended

PeaceHealth United General Medical Center

Sedro-Woolley, Washington, 98284

Suspended

Providence Regional Cancer System-Shelton

Shelton, Washington, 98584

Suspended

Saint Michael Cancer Center

Silverdale, Washington, 98383

Recruiting
Site Public Contact · Contact
720-874-1881ResearchInstituteInquiries@CommonSpirit.org
Shahzad Siddique · Principal Investigator

Cancer Care Northwest - Spokane South

Spokane, Washington, 99202

Suspended

Cancer Care Northwest-Valley

Spokane, Washington, 99216

Suspended

Cancer Care Northwest-North Spokane

Spokane, Washington, 99218

Suspended

Franciscan Research Center-Northwest Medical Plaza

Tacoma, Washington, 98405

Suspended

Northwest Medical Specialties PLLC

Tacoma, Washington, 98405

Suspended

PeaceHealth Southwest Medical Center

Vancouver, Washington, 98664

Suspended

Providence Saint Mary Regional Cancer Center

Walla Walla, Washington, 99362

Suspended

Providence Regional Cancer System-Yelm

Yelm, Washington, 98597

Suspended

West Virginia University Charleston Division

Charleston, West Virginia, 25304

Active Not Recruiting

ThedaCare Regional Cancer Center

Appleton, Wisconsin, 54911

Recruiting
Site Public Contact · Contact
920-364-3604ResearchDept@thedacare.org
Yazhini Vallatharasu · Principal Investigator

Ascension Saint Elizabeth Hospital

Appleton, Wisconsin, 54915

Suspended

SSM Health Dean Medical Group - Baraboo

Baraboo, Wisconsin, 53913

Active Not Recruiting

Ascension Southeast Wisconsin Hospital - Elmbrook Campus

Brookfield, Wisconsin, 53045

Suspended

Aurora Cancer Care-Southern Lakes VLCC

Burlington, Wisconsin, 53105

Suspended

Ascension Calumet Hospital

Chilton, Wisconsin, 53014

Suspended

Marshfield Clinic-Chippewa Center

Chippewa Falls, Wisconsin, 54729

Suspended

Aurora Saint Luke's South Shore

Cudahy, Wisconsin, 53110

Suspended

HSHS Sacred Heart Hospital

Eau Claire, Wisconsin, 54701

Active Not Recruiting

Marshfield Medical Center-EC Cancer Center

Eau Claire, Wisconsin, 54701

Suspended

Ascension Saint Francis - Reiman Cancer Center

Franklin, Wisconsin, 53132

Suspended

Ascension Southeast Wisconsin Hospital - Franklin

Franklin, Wisconsin, 53132

Suspended

Aurora Health Care Germantown Health Center

Germantown, Wisconsin, 53022

Suspended

Aurora Cancer Care-Grafton

Grafton, Wisconsin, 53024

Suspended

Saint Vincent Hospital Cancer Center Green Bay

Green Bay, Wisconsin, 54301

Recruiting
Site Public Contact · Contact
920-433-8889WI_research_admin@hshs.org
Brian L. Burnette · Principal Investigator

Saint Vincent Hospital Cancer Center at Saint Mary's

Green Bay, Wisconsin, 54303

Recruiting
Site Public Contact · Contact
920-433-8889wi_research_admin@hshs.org
Brian L. Burnette · Principal Investigator

Aurora BayCare Medical Center

Green Bay, Wisconsin, 54311

Suspended

SSM Health Dean Medical Group - Janesville

Janesville, Wisconsin, 53546

Active Not Recruiting

University of Wisconsin Carbone Cancer Center - Johnson Creek

Johnson Creek, Wisconsin, 53038

Suspended

Aurora Cancer Care-Kenosha South

Kenosha, Wisconsin, 53142

Suspended

Gundersen Lutheran Medical Center

La Crosse, Wisconsin, 54601

Recruiting
Site Public Contact · Contact
608-775-2385cancerctr@gundersenhealth.org
Kurt Oettel · Principal Investigator

Mayo Clinic Health System-Franciscan Healthcare

La Crosse, Wisconsin, 54601

Suspended

Marshfield Medical Center - Ladysmith

Ladysmith, Wisconsin, 54848

Suspended

William S Middleton VA Medical Center

Madison, Wisconsin, 53705

Recruiting
Site Public Contact · Contact
608-256-1901
Christopher D. Fletcher · Principal Investigator

SSM Health Dean Medical Group - South Madison Campus

Madison, Wisconsin, 53715

Active Not Recruiting

University of Wisconsin Carbone Cancer Center - Eastpark Medical Center

Madison, Wisconsin, 53718

Suspended

University of Wisconsin Carbone Cancer Center - University Hospital

Madison, Wisconsin, 53792

Recruiting
Site Public Contact · Contact
800-622-8922clinicaltrials@cancer.wisc.edu
Timothy M. Schmidt · Principal Investigator

Aurora Bay Area Medical Group-Marinette

Marinette, Wisconsin, 54143

Suspended

Marshfield Medical Center-Marshfield

Marshfield, Wisconsin, 54449

Suspended

Ascension Columbia Saint Mary's Hospital Ozaukee

Mequon, Wisconsin, 53097

Suspended

Aurora Cancer Care-Milwaukee

Milwaukee, Wisconsin, 53209

Suspended

Ascension Southeast Wisconsin Hospital - Saint Joseph Campus

Milwaukee, Wisconsin, 53210

Suspended

Ascension Columbia Saint Mary's Hospital - Milwaukee

Milwaukee, Wisconsin, 53211

Suspended

Ascension Saint Francis Hospital

Milwaukee, Wisconsin, 53215

Suspended

Aurora Saint Luke's Medical Center

Milwaukee, Wisconsin, 53215

Suspended

Aurora Sinai Medical Center

Milwaukee, Wisconsin, 53233

Suspended

Marshfield Medical Center - Minocqua

Minocqua, Wisconsin, 54548

Suspended

ProHealth D N Greenwald Center

Mukwonago, Wisconsin, 53149

Suspended

ThedaCare Regional Medical Center - Neenah

Neenah, Wisconsin, 54956

Recruiting
Site Public Contact · Contact
920-364-3605ResearchDept@thedacare.org
Yazhini Vallatharasu · Principal Investigator

Marshfield Medical Center - Neillsville

Neillsville, Wisconsin, 54456

Suspended

Cancer Center of Western Wisconsin

New Richmond, Wisconsin, 54017

Recruiting
Site Public Contact · Contact
952-993-1517mmcorc@healthpartners.com
David M. King · Principal Investigator

ProHealth Oconomowoc Memorial Hospital

Oconomowoc, Wisconsin, 53066

Suspended

Saint Vincent Hospital Cancer Center at Oconto Falls

Oconto Falls, Wisconsin, 54154

Recruiting
Site Public Contact · Contact
920-433-8889WI_research_admin@hshs.org
Brian L. Burnette · Principal Investigator

Ascension Mercy Hospital

Oshkosh, Wisconsin, 54904

Suspended

Vince Lombardi Cancer Clinic - Oshkosh

Oshkosh, Wisconsin, 54904

Suspended

Ascension All Saints Hospital

Racine, Wisconsin, 53405

Suspended

Aurora Cancer Care-Racine

Racine, Wisconsin, 53406

Suspended

Marshfield Medical Center-Rice Lake

Rice Lake, Wisconsin, 54868

Suspended

Vince Lombardi Cancer Clinic-Sheboygan

Sheboygan, Wisconsin, 53081

Suspended

Marshfield Medical Center-River Region at Stevens Point

Stevens Point, Wisconsin, 54482

Suspended

Saint Vincent Hospital Cancer Center at Sturgeon Bay

Sturgeon Bay, Wisconsin, 54235-1495

Recruiting
Site Public Contact · Contact
920-433-8889wi_research_admin@hshs.org
Brian L. Burnette · Principal Investigator

Aurora Medical Center in Summit

Summit, Wisconsin, 53066

Suspended

Vince Lombardi Cancer Clinic-Two Rivers

Two Rivers, Wisconsin, 54241

Suspended

ProHealth Waukesha Memorial Hospital

Waukesha, Wisconsin, 53188

Suspended

UW Cancer Center at ProHealth Care

Waukesha, Wisconsin, 53188

Suspended

Marshfield Clinic-Wausau Center

Wausau, Wisconsin, 54401

Suspended

Ascension Medical Group Southeast Wisconsin - Mayfair Road

Wauwatosa, Wisconsin, 53226

Suspended

Aurora Cancer Care-Milwaukee West

Wauwatosa, Wisconsin, 53226

Suspended

Aurora West Allis Medical Center

West Allis, Wisconsin, 53227

Suspended

Marshfield Medical Center - Weston

Weston, Wisconsin, 54476

Suspended

Marshfield Clinic - Wisconsin Rapids Center

Wisconsin Rapids, Wisconsin, 54494

Suspended

Memorial Hospital of Laramie County

Cheyenne, Wyoming, 82001

Suspended

Billings Clinic-Cody

Cody, Wyoming, 82414

Suspended

Welch Cancer Center

Sheridan, Wyoming, 82801

Suspended